D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283

Brain Metabolism during Fasting*

Owen, O. E., Morgan, A. P., Kemp, H. G., Sullivan, J. M., Herrera, M. G., & Cahill, G. F. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105650 · Cited by 1,662

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,273

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Javitch, J. A., D’Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,264

Generation of reactive oxygen species by the mitochondrial electron transport chain

Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260

Abnormalities of the electron transport chain in idiopathic parkinson's disease

Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,061

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

Heikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010

Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake

Anson, R. M., Guo, Z., de Cabo, R., Iyun, T., Rios, M., Hagepanos, A., Ingram, D. K., Lane, M. A., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1035720100 · Cited by 732

Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism

D’Alessandro, G., Calcagno, E., Tartari, S., Rizzardini, M., Invernizzi, R. W., & Cantoni, L. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.003 · Cited by 54

d-β-Hydroxybutyrate Prevents Glutamate-Mediated Lipoperoxidation and Neuronal Damage Elicited during Glycolysis Inhibition In Vivo

Mejía-Toiber, J., Montiel, T., & Massieu, L. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9189-5 · Cited by 53

Neuroprotective Therapy in Parkinson Disease

Chen, S., & Le, W. (2006) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000174353.28012.a7 · Cited by 53

Protection against Oxidant-Induced Apoptosis by Exogenous Glutathione in Leber Hereditary Optic Neuropathy Cybrids

Ghelli, A. M., Porcelli, A. M., Zanna, C., Martinuzzi, A., Carelli, V., & Rugolo, M. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0880 · Cited by 53

Acute upregulation of neuronal mitochondrial type-1 cannabinoid receptor and it’s role in metabolic defects and neuronal apoptosis after TBI

Xu, Z., Lv, X., Dai, Q., Ge, Y., & Xu, J. (2016) · Molecular Brain · doi:10.1186/s13041-016-0257-8 · Cited by 53

From the Cover: Harmane-Induced Selective Dopaminergic Neurotoxicity in Caenorhabditis elegans

Sammi, S. R., Ağım, Z. S., & Cannon, J. R. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx223 · Cited by 53

The energy–redox axis in aging and age-related neurodegeneration☆

Yap, L.-P., Garcia, J., Han, D., & Cadenas, E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.015 · Cited by 56

Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach

Gonzalez-Riano, C., Saiz, J., Barbas, C., Bergareche, A., Huerta, J. M., Ardanaz, E., Konjevod, M., Mondragon, E., Erro, M. E., Chirlaque, M. D., et al. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00216-4 · Cited by 49

Role of Medium Chain Triglycerides (Axona ® ) in the Treatment of Mild to Moderate Alzheimer’s Disease

Sharma, A. K., Bemis, M., & Desilets, A. R. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518650 · Cited by 54

Ketogenic diet protects MPTP‐induced mouse model of Parkinson's disease via altering gut microbiota and metabolites

Jiang, Z., Wang, X., Zhang, H., Yin, J., Zhao, P., Yin, Q., & Wang, Z. (2023) · MedComm · doi:10.1002/mco2.268 · Cited by 50

Effects of Histone Modification in Major Depressive Disorder

Wu, M.-S., Li, X., Liu, C., Xu, Q., Huang, J., Gu, S., & Chen, J. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210922150043 · Cited by 56

The Evolution of Ketosis: Potential Impact on Clinical Conditions

Dilliraj, L. N., Schiuma, G., Lara, D., Strazzabosco, G., Clement, J., Giovannini, P. P., Trapella, C., Narducci, M., & Rizzo, R. (2022) · Nutrients · doi:10.3390/nu14173613 · Cited by 54

Nutritional habits, risk, and progression of Parkinson disease

Erro, R., Brigo, F., Tamburin, S., Zamboni, M. M., Antonini, A., & Tinazzi, M. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8639-0 · Cited by 56

Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model

Yamanashi, T., Iwata, M., Shibushita, M., Tsunetomi, K., Nagata, M., Kajitani, N., Miura, A., Matsuo, R., Nishiguchi, T., Kato, T. A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78410-2 · Cited by 53

Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain

Balietti, M., Casoli, T., Stefano, G. D., Giorgetti, B., Aicardi, G., & Fattoretti, P. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.02.003 · Cited by 50

Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review

Caplliure‐Llopis, J., Chamba, T. P., Carrera‐Juliá, S., Cuerda‐Ballester, M., Drehmer, E., López‐Rodriguez, M. M., & Ortí, J. E. D. L. R. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1324 · Cited by 51

Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression

Kajitani, N., Iwata, M., Miura, A., Tsunetomi, K., Yamanashi, T., Matsuo, R., Nishiguchi, T., Fukuda, S., Nagata, M., Shibushita, M., et al. (2020) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12099 · Cited by 49

Beta-Hydroxybutyrate, Friend or Foe for Stressed Hearts

Chu, Y., Zhang, C., & Xie, M. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.681513 · Cited by 52

Applications of Ketogenic Diets in Patients with Headache: Clinical Recommendations

Lorenzo, C. D., Ballerini, G., Barbanti, P., Bernardini, A., D’Arrigo, G., Egeo, G., Frediani, F., Garbo, R., Pierangeli, G., Prudenzano, M. P., et al. (2021) · Nutrients · doi:10.3390/nu13072307 · Cited by 53

Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production

Lam, P. Y., Yin, F., Hamilton, R. T., BOVERIS, A., & Cadenas, E. (2009) · Free Radical Research · doi:10.1080/10715760902849813 · Cited by 49

The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?☆

Lee, J.-H., Boo, J. H., & Ryu, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.016 · Cited by 51

Energy and the Alzheimer brain

Mamelak, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.001 · Cited by 47

Measuring ketone bodies for the monitoring of pathologic and therapeutic ketosis

Anderson, J. C., Mattar, S. G., Greenway, F. L., & Lindquist, R. J. (2021) · Obesity Science & Practice · doi:10.1002/osp4.516 · Cited by 52

Ketogenic diets and Ketone suplementation: A strategy for therapeutic intervention

Saris, C. G. J., & Timmers, S. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.947567 · Cited by 50

Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat—possible involvement of kynurenic acid

Thaler, S., Chorągiewicz, T., Ręjdak, R., Fiedorowicz, M., Turski, W. A., Tulidowicz-Bielak, M., Zrenner, E., Schuettauf, F., & Żarnowski, T. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1425-7 · Cited by 46

Mitochondrial Transplantation: A Novel Therapeutic Approach for Treating Diseases

Miao, X., Jiang, P., Wang, Z., Kong, W., & Feng, L. (2025) · MedComm · doi:10.1002/mco2.70253 · Cited by 54

Exploring the ketogenic diet’s potential in reducing neuroinflammation and modulating immune responses

Monda, A., Torre, M. E. L., Messina, A., Maio, G. D., Monda, V., Moscatelli, F., Stefano, M. D., Marra, M. L., di Padova, M., Dipace, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425816 · Cited by 50

LRRK 2 R1441G mice are more liable to dopamine depletion and locomotor inactivity

Liu, H., Song, L., Ho, P. W., Tse, H., Pang, S. Y., Kung, M. H.-W., Ho, J. W.-M., Ramsden, D. B., Zhou, Z., & Ho, S. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.45 · Cited by 43

Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases

Camberos-Luna, L., & Massieu, L. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104614 · Cited by 44

Synergistic Exacerbation of Mitochondrial and Synaptic Dysfunction and Resultant Learning and Memory Deficit in a Mouse Model of Diabetic Alzheimer's Disease

Wang, Y., Wu, L., Li, J., Du, F., Zhong, C., Chen, J. X., & Yan, S. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140972 · Cited by 43

d-β-Hydroxybutyrate inhibited the apoptosis of PC12 cells induced by H2O2 via inhibiting oxidative stress

Cheng, B., Lu, H., Bai, B., & Chen, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.09.011 · Cited by 42

Partial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage

Peralta, S., Torraco, A., Wenz, T., Garcia, S., Diaz, F., & Moraes, C. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt526 · Cited by 42

Diet and medical foods in Parkinson’s disease

Lange, K. W., NAKAMURA, Y., Chen, N., Guo, J., Kanaya, S., Lange, K. M., & Li, S. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.03.006 · Cited by 43

GDF11 alleviates secondary brain injury after intracerebral hemorrhage via attenuating mitochondrial dynamic abnormality and dysfunction

Xiao, A., Yiqi, Z., Ren, Y., Chen, R., Li, T., You, C., & Gan, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-83545-x · Cited by 43

Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies

Meng, X., Zhang, H., Zhao, Z., Li, S., Zhang, X., Guo, R., Li, H., Yuan, Y., Li, W., Song, Q., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01101-z · Cited by 47

Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease

Westfall, S., Iqbal, U. H., Sebastian-Valverde, M., & Pasinetti, G. M. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.013 · Cited by 42

N-Propargyl Caffeamide (PACA) Ameliorates Dopaminergic Neuronal Loss and Motor Dysfunctions in MPTP Mouse Model of Parkinson’s Disease and in MPP+-Induced Neurons via Promoting the Conversion of proNGF to NGF

Luo, D., Zhao, J., Cheng, Y., Lee, S. M., & Rong, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0486-6 · Cited by 40

Exogenous Ketone Bodies as Promising Neuroprotective Agents for Developmental Brain Injury

Wood, T. R., Stubbs, B. J., & Juul, S. E. (2018) · Developmental Neuroscience · doi:10.1159/000499563 · Cited by 41

Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?

Morris, G., Puri, B. K., Carvalho, A. F., Maes, M. H. J., Berk, M., Ruusunen, A. A., & OLIVE, L. S. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa008 · Cited by 42

Targeting Neurovascular Interaction in Retinal Disorders

Fu, Z., Sun, Y., Cakir, B., Tomita, Y., Huang, S., Wang, Z., Liu, C., Cho, S. S., Britton, W. R., Kern, T. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041503 · Cited by 43

Beta-Hydroxybutyrate Enhances BDNF Expression by Increasing H3K4me3 and Decreasing H2AK119ub in Hippocampal Neurons

Hu, E., Du, H., Shang, S., Zhang, Y., & Lu, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.591177 · Cited by 40

The Chemistry of the Ketogenic Diet: Updates and Opportunities in Organic Synthesis

Williams, M. S., & Turos, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105230 · Cited by 43

Ulcerative colitis: functional analysis of the in-depth proteome

Schniers, A., Goll, R., Pasing, Y., Sørbye, S. W., Florholmen, J. R., & Hansen, T. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9224-6 · Cited by 38

Gemfibrozil Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease via PPARα-Dependent Astrocytic GDNF Pathway

Gottschalk, C. G., Jana, M., Roy, A., Patel, D. R., & Pahan, K. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.3018-19.2021 · Cited by 39

A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease

Norwitz, N. G., Dearlove, D., Lü, M., Clarke, K., Dawes, H., & Hu, M. T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.584130 · Cited by 43

Ionic-Liquid-Based Heterogeneous Covalent Triazine Framework Cobalt Catalyst for the Direct Synthesis of Methyl 3-Hydroxybutyrate from Propylene Oxide

Rajendiran, S., Park, K., Lee, K., & Yoon, S. (2017) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b00974 · Cited by 37

The Ketone Body β-Hydroxybutyrate Does Not Inhibit Synuclein Mediated Inflammasome Activation in Microglia

Deora, V., Albornoz, E. A., Zhu, K., Woodruff, T. M., & Gordon, R. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9754-5 · Cited by 36

d-β-hydroxybutyrate inhibits the apoptosis of PC12 cells induced by 6-OHDA in relation to up-regulating the ratio of Bcl-2/Bax mRNA

Cheng, B., Yang, X., Hou, Z., Lin, X., Meng, H., Li, Z., & Liu, S. (2007) · Autonomic Neuroscience · doi:10.1016/j.autneu.2007.02.002 · Cited by 37

Neuroprotection in metabolism-based therapy

Hartman, A. L. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.04.016 · Cited by 39

Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson’s Disease

Goiran, T., Eldeeb, M. A., Zorca, C. E., & Fon, E. A. (2022) · Cells · doi:10.3390/cells11132097 · Cited by 38

Low-Carbohydrate High-Fat Diet: A SWOC Analysis

Nuwaylati, D. A., Eldakhakhny, B. M., Bima, A. I. H., Sakr, H. F., & Elsamanoudy, A. Z. (2022) · Metabolites · doi:10.3390/metabo12111126 · Cited by 39

Long-term Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson’s Disease

Huang, D., Wang, Z., Tong, J., Wang, M., Wang, J., Xu, J., Bai, X., Li, H., Huang, Y., Wu, Y., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.11.041 · Cited by 36

Myricetin prevents dopaminergic neurons from undergoing neuroinflammation-mediated degeneration in a lipopolysaccharide-induced Parkinson’s disease model

Huang, B., Liu, J., Ma, D., Chen, G., Wang, W., & Fu, S. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.018 · Cited by 36

A heterogenized cobaltate catalyst on a bis-imidazolium-based covalent triazine framework for hydroesterification of epoxides

Rajendiran, S., Gunasekar, G. H., & Yoon, S. (2018) · New Journal of Chemistry · doi:10.1039/c8nj02292e · Cited by 36

Early Motor-Behavioral Outcome of Ischemic Stroke with Ketogenic Diet Preconditioning: Interventional Animal Study

Shaafi, S., Sharifi‐Bonab, M., Ghaemian, N., Mokhtarkhani, M., & Akbari, H. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.12.024 · Cited by 36

Beyond Intracellular Accumulation of Polyhydroxyalkanoates: Chiral Hydroxyalkanoic Acids and Polymer Secretion

Yáñez, L., Conejeros, R., Vergara‐Fernández, A., & Scott, F. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00248 · Cited by 36

KTX 0101: A Potential Metabolic Approach to Cytoprotection in Major Surgery and Neurological Disorders

Smith, S. L., Heal, D. J., & Martin, K. F. (2005) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00265.x · Cited by 36

Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?

Vekaria, H. J., Watts, L. T., Lin, A., & Sullivan, P. G. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.04.004 · Cited by 35

Ketone Bodies and Brain Metabolism: New Insights and Perspectives for Neurological Diseases

López-Ojeda, W., & Hurley, R. A. (2023) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20230017 · Cited by 35

Caloric restriction promotes cell survival in a mouse model of normal tension glaucoma

Guo, X., Kimura, A. K., Azuchi, Y., Akiyama, G., Noro, T., Harada, C., Namekata, K., & Harada, T. (2016) · Scientific Reports · doi:10.1038/srep33950 · Cited by 34

Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson’s disease

Joniec‐Maciejak, I., Wawer, A., Turzyńska, D., Sobolewska, A., Maciejak, P., Szyndler, J., Mirowska-Guzel, D. M., & Płaźnik, A. (2018) · Pharmacological Reports · doi:10.1016/j.pharep.2018.04.008 · Cited by 34

Evaluation of a ketogenic diet for improvement of neurological recovery in individuals with acute spinal cord injury: a pilot, randomized safety and feasibility trial

Yarar‐Fisher, C., Kulkarni, A., Li, J., Farley, P., Renfro, C., Aslam, H., Bosarge, P. L., Wilson, L. S., & Barnes, S. (2018) · Spinal Cord Series and Cases · doi:10.1038/s41394-018-0121-4 · Cited by 34

Imaging the Effects of β-Hydroxybutyrate on Peri-Infarct Neurovascular Function and Metabolism

Bazzigaluppi, P., Lake, E. M. R., Beckett, T. L., Koletar, M. M., Weisspapir, I., Heinen, S., Mester, J. R., Lai, A. Y., Janik, R., Dorr, A. E., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.020586 · Cited by 34

β-hydroxybutyrate Impedes the Progression of Alzheimer’s Disease and Atherosclerosis in ApoE-Deficient Mice

Krishnan, M., Hwang, J. S., Kim, M. K., Kim, Y. J., Seo, J. H., Jung, J., & Ha, E. (2020) · Nutrients · doi:10.3390/nu12020471 · Cited by 34

Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder

Mahajan, V. R., Elvig, S. K., Vendruscolo, L. F., Koob, G. F., Darcey, V. L., King, M. T., Kranzler, H. R., Volkow, N. D., & Wiers, C. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.781668 · Cited by 34

The Mouse Brain Metabolome

Jaeger, C., Glaab, E., Michelucci, A., Binz, T. M., Köglsberger, S., Garcia, P., Trezzi, J., Ghelfi, J., Balling, R., & Buttini, M. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.016 · Cited by 32

Potential benefits of medium chain fatty acids in aging and neurodegenerative disease

Dunn, E., Zhang, B., Sahota, V. K., & Augustin, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1230467 · Cited by 38

A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people with Parkinson's disease

Choi, A. H., Delgado, M., Chen, K. Y., Chung, S. T., Courville, A. B., Turner, S. A., Yang, S. B., Airaghi, K. J., Dustin, I. M., McGurrin, P. M., et al. (2024) · BMC Neurology · doi:10.1186/s12883-024-03603-5 · Cited by 37

The role of exerkines on brain mitochondria: a mini-review

Heo, J., Noble, E. E., & Call, J. A. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00565.2022 · Cited by 37

Low-carb diets, fasting and euphoria: Is there a link between ketosis and γ-hydroxybutyrate (GHB)?

Brown, A. J. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.07.043 · Cited by 33

Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders

McDonald, T. S., Lerskiatiphanich, T., Woodruff, T. M., McCombe, P., & Lee, J. D. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221135061 · Cited by 36

β-hydroxybutyrate (β-HB) exerts anti-inflammatory and antioxidant effects in lipopolysaccharide (LPS)-stimulated macrophages in Liza haematocheila

Qiao, G., Lv, T., Zhang, M., Chen, P., Sun, Q., Zhang, J., & Li, Q. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.11.005 · Cited by 33

Ketogenic Diet Decreases Alcohol Intake in Adult Male Mice

Blanco-Gandía, M. C., Ródenas-González, F., Pascual, M., Reguilón, M. D., Guerri, C., Miñarro, J., & Rodríguez‐Arias, M. (2021) · Nutrients · doi:10.3390/nu13072167 · Cited by 32

Nutritional Ketosis in Parkinson's Disease — a Review of Remaining Questions and Insights

Choi, A. H., Hallett, M., & Ehrlich, D. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01067-w · Cited by 35

Ketone bodies protection against HIV‐1 Tat‐induced neurotoxicity

Liang, H., Chen, X., Bhatt, D. P., Geiger, N. H., Rosenberger, T. A., Haughey, N. J., Masino, S. A., & Geiger, J. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07764.x · Cited by 32

Metabolic Responses in Endothelial Cells Following Exposure to Ketone Bodies

Meroni, E., Papini, N., Criscuoli, F., Casiraghi, M. C., Massaccesi, L., Basilico, N., & Erba, D. (2018) · Nutrients · doi:10.3390/nu10020250 · Cited by 31

Impact of the Ketogenic Diet on Neurological Diseases: A Review

Rubio, C., López-Landa, A., Parra, H. R., & Rubio‐Osornio, M. (2025) · Life · doi:10.3390/life15010071 · Cited by 35

Increased Beta-Hydroxybutyrate Level Is Not Sufficient for the Neuroprotective Effect of Long-Term Ketogenic Diet in an Animal Model of Early Parkinson’s Disease. Exploration of Brain and Liver Energy Metabolism Markers

Kuter, K. Z., Olech, Ł., Głowacka, U., & Paleczna, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147556 · Cited by 30

Extracellular Redox Regulation of Intracellular Reactive Oxygen Generation, Mitochondrial Function and Lipid Turnover in Cultured Human Adipocytes

Jones, A. R., Meshulam, T., de Oliveira, M. F., Burritt, N. E., & Corkey, B. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164011 · Cited by 30

Enhancement of L-3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury

Cornille, E., Abou-Hamdan, M., Khrestchatisky, M., Nieoullon, A. L., Reggi, M. L. D., & Gharib, B. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-51 · Cited by 30

Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential

Lv, R., Liu, B., Jiang, Z., Zhou, R., Liu, X., Lu, T., Bao, Y., Huang, C., Zou, G., Zhang, Z., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156104 · Cited by 34

β-Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells

Mikami, D., Kobayashi, M., Uwada, J., Yazawa, T., Kamiyama, K., Nishimori, K., Nishikawa, Y., Morikawa, Y., Yokoi, S., Takahashi, N., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.008 · Cited by 31

Cerebral ketone metabolism during development and injury

Prins, M. L. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.09.027 · Cited by 29

Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice

Koch, K. A., Berressem, D., Konietzka, J., Thinnes, A., Eckert, G. P., & Klein, J. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005556 · Cited by 29

Ketone bodies in cell physiology and cancer

Giuliani, G., & Longo, V. D. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00441.2023 · Cited by 31

Therapeutic potential of the ketogenic diet: A metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases

Shahpasand, S., Khatami, S. H., Ehtiati, S., Alehossein, P., Salmani, F., Toutounchi, A. H., Zarei, T., Shahmohammadi, M. R., Khodarahmi‬, R., Aghamollaii, V., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109693 · Cited by 29

Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases

Butterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022) · Molecules · doi:10.3390/molecules27030951 · Cited by 29

Ketone Body Therapy Protects From Lipotoxicity and Acute Liver Failure Upon Pparα Deficiency

Pawlak, M., Baugé, E., Lalloyer, F., Lefèbvre, P., & Staels, B. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1383 · Cited by 30

βOHB Protective Pathways in Aralar-KO Neurons and Brain: An Alternative to Ketogenic Diet

Pérez-Liébana, I., Casarejos, M. J., Alcaide, A., Herrada-Soler, E., Llorente‐Folch, I., Contreras, L., Satrústegui, J., & Pardo, B. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0711-20.2020 · Cited by 27

Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis

Chu, C., Yu, L., Chen, W., Tian, F., & Zhai, Q. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.07.004 · Cited by 27

AGC1 Deficiency: Pathology and Molecular and Cellular Mechanisms of the Disease

Pardo, B., Herrada-Soler, E., Satrústegui, J., Contreras, L., & del Arco, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010528 · Cited by 31

Enantioselective and simultaneous determination of lactate and 3‐hydroxybutyrate in human plasma and urine using a narrow‐bore online two‐dimensional high‐performance liquid chromatography system

Hsieh, C., Koga, R., Furusho, A., Akita, T., Mita, M., Ide, T., Lee, J., & Hamase, K. (2018) · Journal of Separation Science · doi:10.1002/jssc.201701283 · Cited by 27

Recent Progress on the Discovery of NLRP3 Inhibitors and their Therapeutic Potential

Su, M., Wang, W., Liu, F., & Li, H. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200123093544 · Cited by 26

3‐hydroxybutyrate in the brain: Biosynthesis, function, and disease therapy

Wang, B., Wu, J., Xiao, D., Wu, B., & Wei, D. (2023) · Brain‐X · doi:10.1002/brx2.6 · Cited by 26

Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast

Li, G., Wang, M., Hao, L., Loo, W. T.-Y., Jin, L., Cheung, M., Chow, L. W. C., & Ng, E. L. Y. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.02.015 · Cited by 26

Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet

Farrés, J., Pujol, A., Coma, M., Ruiz, J. L., Naval, J., Mas, J. M., Molins, A. B., Fondevila, J., & Aloy, P. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-88 · Cited by 28

Ketogenic diet administration later in life improves memory by modifying the synaptic cortical proteome via the PKA signaling pathway in aging mice

Acuña-Catalán, D., Shah, S., Wehrfritz, C., Nomura, M., Acevedo, A., Olmos, C., Quiroz, G., Huerta, H., Bons, J., Ampuero, E., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101593 · Cited by 29

Dietary carbohydrates modulate metabolic and β-cell adaptation to high-fat diet-induced obesity

Her, T. K., Lagakos, W., Brown, M., LeBrasseur, N. K., Rakshit, K., & Matveyenko, A. V. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00539.2019 · Cited by 24

Ketotherapeutics for neurodegenerative diseases

Norwitz, N. G., Gilbert‐Jaramillo, J., Clarke, K., & Soto-Mota, A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.003 · Cited by 24

Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models

Ari, C., Murdun, C., Goldhagen, C. R., Koutnik, A. P., Bharwani, S., Diamond, D. M., Kindy, M. S., D’Agostino, D. P., & Kovács, Z. (2020) · Nutrients · doi:10.3390/nu12082459 · Cited by 23

d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease

Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 534

D‐β‐hydroxybutyrate protects dopaminergic SH‐SY5Y cells in a rotenone model of Parkinson's disease

Imamura, K., Takeshima, T., Kashiwaya, Y., Nakaso, K., & Nakashima, K. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21021 · Cited by 101

The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's Disease

Norwitz, N. G., Hu, M. T., & Clarke, K. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00063 · Cited by 110

Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson’s Disease

Kim, Y., Choi, S. Y., Hwang, O., & Lee, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03017-9 · Cited by 14

β-Hydroxybutyrate alleviates pyroptosis in MPP+/MPTP-induced Parkinson’s disease models via inhibiting STAT3/NLRP3/GSDMD pathway

Jiang, Z., Yin, X., Wang, M., Wang, Y., Li, F., Gao, Y., Han, G., Gao, Z., & Wang, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109451 · Cited by 61